Senior Director, Global Regulatory Submissions & Operations
Meet Life Sciences
Boston (MA)
Hybrid
USD 150,000 - 190,000
Full time
14 days+
Application generator
A complete application in a minute — tailored resume and cover letter, ready to send.
Get past ATS filters
Benefits offered by this job
Competitive salary
Bonus
Equity
Benefits package
Job summary
A leading biotechnology company in Boston is seeking a Senior Manager for Regulatory Affairs Operations. In this hybrid role, you will lead global regulatory submissions and collaborate across teams to ensure timely delivery of regulatory documents. The ideal candidate has 6+ years of regulatory affairs experience, strong skills in eCTD publishing, and works well in cross-functional settings. This position offers competitive compensation and the opportunity to contribute to innovative oncology therapies.
Qualifications
6+ years of experience in Regulatory Affairs within pharma or biotech.
Strong experience with global regulatory submissions and eCTD publishing.
Hands-on experience with regulatory information management systems.
Responsibilities
Act as Regulatory Operations Lead for submission planning and execution.
Coordinate and manage global regulatory submissions (IND, CTA, NDA).
Ensure regulatory documentation meets global eCTD submission standards.
Skills
Global regulatory submissions
eCTD publishing
Regulatory information management systems
Cross-functional collaboration
Project coordination
Education
Bachelor's or Master's degree in a life sciences discipline
Tools
Veeva RIM
Job description
A leading biotechnology company in Boston is seeking a Senior Manager for Regulatory Affairs Operations. In this hybrid role, you will lead global regulatory submissions and collaborate across teams to ensure timely delivery of regulatory documents. The ideal candidate has 6+ years of regulatory affairs experience, strong skills in eCTD publishing, and works well in cross-functional settings. This position offers competitive compensation and the opportunity to contribute to innovative oncology therapies.